Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01006109 · ClinicalTrials.gov registry record
Recording and Modulation of Neuronal Mechanisms During Operant Conditioning: a MEG Study
A clinical trial, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Terminated
- Registry status
- 20
- Enrollment target
NCT01006109 is a clinical trial that was terminated before completion, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 20 participants.
The verdict
NCT01006109 was terminated before completion, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- TERMINATED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Background: \- Most of the time, humans make decisions according to their consequences, especially if they will be beneficial, and will avoid or try to avoid doing an action if it has a bad outcome. The way that the brain prepares a movement has been studied in detail, but the way the brain makes decisions before carrying out an action is still poorly understood. Researchers are interested in learning more about the decision-making process and how it affects the brain. Objectives: \- To record the activity of the brain during decision-making processes. Eligibility: \- Healthy, right-handed volunteers between 18 and 40 years of age. Design: * Potential participants will have a screening visit with a medical history and neurological examination to determine eligibility. * This study requires seven visits: one magnetic resonance imaging (MRI) visit and 6 magnetoencephalography (MEG) recording visits. The MEG recording visits will include transcranial magnetic stimulation (TMS). All visits will be spaced at least 1 week apart. Total participation will last about 6 weeks. * Participants will have an MRI scan at the first study visit. * The MEG procedures will record brain activity during a series of computer tests involving winning or losing money. TMS will be performed during these visits, separate from the test....
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-10-22 |
| Est. Completion | 2017-09-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01006109
The ClinicalTrials.gov registry entry for NCT01006109 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01006109 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01006109 about?
NCT01006109 is a clinical study titled "Recording and Modulation of Neuronal Mechanisms During Operant Conditioning: a MEG Study". Background: \- Most of the time, humans make decisions according to their consequences, especially if they will be beneficial, and will avoid or try to avoid doing an action if it has a bad outcome. The way that the brain prepares a movement has been studied in detail, but the way the brain makes d...
What is the current status of trial NCT01006109?
This trial is currently terminated. The enrollment target is 20 participants. The study started on 2009-10-22. Estimated completion is 2017-09-07.
Who is sponsoring clinical trial NCT01006109?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.